SCHEMBL7843657

SCHEMBL7843657

C#Cc1cccc(Nc2cc(NC3CCN(CC(=O)OC)CC3)ncn2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.48
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43
TUBA3C P0DPH7 1/20 0.43
TUBA1B P68363 1/20 0.43
TUBA4A P68366 1/20 0.43
TUBB4B P68371 1/20 0.43
TUBB3 Q13509 1/20 0.43
TUBB2A Q13885 1/20 0.43
TUBB8 Q3ZCM7 1/20 0.43
TUBA3E Q6PEY2 1/20 0.43
TUBA1A Q71U36 1/20 0.43
TUBA1C Q9BQE3 1/20 0.43
TUBB6 Q9BUF5 1/20 0.43
TUBB2B Q9BVA1 1/20 0.43
TUBB1 Q9H4B7 1/20 0.43
ERBB2 P04626 7/20 0.40
HDAC3 O15379 5/20 0.39
HDAC4 P56524 5/20 0.39
HDAC1 Q13547 5/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7855902 0.97 EGFR (0.46) EGFRTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL7854904 0.91 EGFR (0.47) EGFRTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL7855967 0.90 EGFR (0.43) EGFRTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL7855879 0.89 EGFR (0.45) EGFRGAKWNT1GSK3BDYRK1A
SCHEMBL7689040 0.87 EGFR (0.47) EGFRTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL7853574 0.86 EGFR (0.41) EGFRTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL7851398 0.86 EGFR (0.50) EGFRTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL7696986 0.86 EGFR (0.51) EGFRTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL7577697 0.86 EGFR (0.59) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL7582363 0.84 EGFR (0.52) EGFRERBB2HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163242-A2 BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESSES FOR PREPARING THEM Boehringer Ingelheim Pharma KG (DE) 2001-12-19 EP disclosed
WO-2000055162-A2 BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESSES FOR PREPARING THEM BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-09-21 WO disclosed